{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:47:19Z","timestamp":1786636039534,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0301-4738.58472","type":"journal-article","created":{"date-parts":[[2009,12,21]],"date-time":"2009-12-21T23:29:52Z","timestamp":1261438192000},"page":"55","source":"Crossref","is-referenced-by-count":32,"title":["Low-dose cyclosporine treatment for sight-threatening uveitis: Efficacy, toxicity, and tolerance"],"prefix":"10.4103","volume":"58","author":[{"given":"D","family":"Mathews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NP","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.58472-1","unstructured":"Borel JF. The history of cyclosporin A and its significance. In: White DJ, editor. Cyclosporin A; Proceedings of an International Conference on Cylosporin A, Cambridge, September 1981. Amsterdam: Elsevier Biomedical Press; 1982. p. 5-17."},{"key":"key-10.4103\/0301-4738.58472-2","first-page":"1075","volume-title":"Cyclosporin A, a peptide metabolite from Trichoderma polysporum Rifai, with a remarkable immunosuppressive activity","author":"Ruegger","year":"1976","journal-title":"Helv Chim Acta"},{"key":"key-10.4103\/0301-4738.58472-3","first-page":"688","volume-title":"Prolonged survival of corneal allografts in rabbits treated with cyclosporin A","author":"Coster","year":"1979","journal-title":"Lancet"},{"key":"key-10.4103\/0301-4738.58472-4","first-page":"1146","volume-title":"Modulation of experimental autommune uveitis with cyclosporin A","author":"Nussenblatt","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.58472-5","first-page":"235","volume-title":"Treatment of intraocular inflammatory disease with cylosporin A","author":"Nussenblatt","year":"1983","journal-title":"Lancet"},{"key":"key-10.4103\/0301-4738.58472-6","first-page":"344","volume-title":"Cyclosporin in the treatment of severe chronic idiopathic uveitis","author":"De","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.58472-7","first-page":"39","volume-title":"Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behcet\u2032s disease","author":"Whitcup","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.58472-8","first-page":"17","volume-title":"Cyclosporin A treatment of Behcet\u2032s disease: a long-term study","author":"Diaz-Llopis","year":"1990","journal-title":"Curr Eye Res"},{"key":"key-10.4103\/0301-4738.58472-9","first-page":"241","volume-title":"Low dose cyclosporin A versus pulsed cyclophosphamide in Behcet\u2032s syndrome: a single masked trial","author":"Ozyazgan","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.58472-10","first-page":"CD001084","volume-title":"Pharmacotherapy for Behcet\u2032s syndrome","author":"Saenz","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0301-4738.58472-11","first-page":"2962","volume-title":"Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: follow-up study","author":"Bagnis","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/0301-4738.58472-12","first-page":"211","volume-title":"Calcineurin inhibitor-induced headache: clinical characteristics and possible mechanisms","author":"Ferrari","year":"2005","journal-title":"Headache"},{"key":"key-10.4103\/0301-4738.58472-13","first-page":"S84","volume-title":"Cyclosporine for Behcet\u2032s uveitis: is it associated with an increased risk of neurological involvement?","author":"Akman-Demir","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"key-10.4103\/0301-4738.58472-14","first-page":"634","volume-title":"Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis","author":"Murphy","year":"2005","journal-title":"Arch Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:53:06Z","timestamp":1786632786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0301-4738.58472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"alternative-id":["58472"],"URL":"https:\/\/doi.org\/10.4103\/0301-4738.58472","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}